Substance / Medication

Levofloxacin

Overview

Active Ingredient
levofloxacin
RxNorm CUI
82122
Labeler: Wockhardt LimitedUpdated: 2012-10-17T00:00:00.000ZFull label on DailyMed

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

9 trials linked to this intervention

9
Total Trials
1
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Prophylactic fluoroquinolones in hematopoietic stem cell transplant recipients: A meta-analytic comparison of ciprofloxacin and levofloxacin.
Albalawi Mohammed A Hameed, Al-Sayaghi Khaled Mohammed, Hegazy Samya Mohamed et al. · Medicine (Baltimore) · 2025
PMID: 40355203Meta-AnalysisFull text (PMC)
A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis.
Duong Trinh, Brigden Joanna, Simon Schaaf H et al. · NEJM Evid · 2025
PMID: 39693627Meta-Analysis
Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis.
White Yasmine N, Solans Belen P, Denti Paolo et al. · Clin Infect Dis · 2024
PMID: 38340060Meta-AnalysisFull text (PMC)
Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review.
Inbaraj Leeberk Raja, Shewade Hemant Deepak, Daniel Jefferson et al. · Front Med (Lausanne) · 2023
PMID: 37415768Meta-AnalysisFull text (PMC)
Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis.
Keikha Masoud, Askari Parvin, Ghazvini Kiarash et al. · J Glob Antimicrob Resist · 2022
PMID: 34788690Meta-Analysis
A systematic review and meta-analysis of levofloxacin and ciprofloxacin in the treatment of urinary tract infection.
Xue Zhisong, Xiang Ying, Li Yutao et al. · Ann Palliat Med · 2021
PMID: 34628902Meta-Analysis
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis.
Bientinesi Riccardo, Murri Rita, Sacco Emilio · Expert Opin Pharmacother · 2020
PMID: 32004097Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Levofloxacin (substance)
SNOMED CT
387552007
UMLS CUI
C0282386
RxNorm CUI
82122
Labeler
Wockhardt Limited

Clinical Data

This intervention maps to 20 entities in the Ltrl knowledge graph.

20
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
9
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.